• Bai, W., Cui, X., Chen, R., Tao, S., Hong, R., Zhang, J., Zhang, J., Wang, Y., Xie, Y., Liu, J., 2016. Re-designed recombinant hepatitis b virus vectors enable efficient delivery of versatile cargo genes to hepatocytes with improved safety. Viruses 8, 129.

  • Chang, H.K., Wang, B.Y., Yuh, C.H., Wei, C.L., Ting, L.P., 1989. A liver-specific nuclear factor interacts with the promoter region of the large surface protein gene of human hepatitis b virus. Mol. Cell Biol. 9, 5189–5197.

  • Chen, R., Zhu, D., Ye, X., Shen, D., Lu, R., 1980. Establishment of three human liver carcinoma cell lines and some of their biological characteristics in vitro. Sci. Sin. 23, 236–247.

  • Gao, W., Hu, J., 2007. Formation of hepatitis b virus covalently closed circular DNA:removal of genome-linked protein. J. Virol. 81, 6164–6174.

  • Garcia, A.D., Ostapchuk, P., Hearing, P., 1993. Functional interaction of nuclear factors ef-c, hnf-4, and rxr alpha with hepatitis b virus enhancer i. J. Virol. 67, 3940–3950.

  • Gripon, P., Rumin, S., Urban, S., Le Seyec, J., Glaise, D., Cannie, I., Guyomard, C., Lucas, J., Trepo, C., Guguen-Guillouzo, C., 2002. Infection of a human hepatoma cell line by hepatitis b virus. Proc. Natl. Acad. Sci. U. S. A. 99, 15655–15660.

  • Guo, H., Mao, R., Block, T.M., Guo, J.T., 2010. Production and function of the cytoplasmic deproteinized relaxed circular DNA of hepadnaviruses. J. Virol. 84, 387–396.

  • Guo, H., Jiang, D., Zhou, T., Cuconati, A., Block, T.M., Guo, J.T., 2007. Characterization of the intracellular deproteinized relaxed circular DNA of hepatitis b virus: an intermediate of covalently closed circular DNA formation. J. Virol. 81, 12472–12484.

  • Hirt, B., 1967. Selective extraction of polyoma DNA from infected mouse cell cultures.J. Mol. Biol. 26, 365–369.

  • Huang, Y., Liu, Y., Zheng, C., Shen, C., 2017. Investigation of cross-contamination and misidentification of 278 widely used tumor cell lines. PLoS One 12, e0170384.

  • Iwamoto, M., Watashi, K., Tsukuda, S., Aly, H.H., Fukasawa, M., Fujimoto, A., Suzuki, R., Aizaki, H., Ito, T., Koiwai, O., Kusuhara, H., Wakita, T., 2014. Evaluation and identification of hepatitis b virus entry inhibitors using hepg2 cells overexpressing a membrane transporter ntcp. Biochem. Biophys. Res. Commun. 443, 808–813.

  • Jia, L., Gao, Y., He, Y., Hooper, J.D., Yang, P., 2020. Hbv induced hepatocellular carcinoma and related potential immunotherapy. Pharmacol. Res. 159, 104992.

  • Konig, A., Doring, B., Mohr, C., Geipel, A., Geyer, J., Glebe, D., 2014. Kinetics of the bile acid transporter and hepatitis b virus receptor naþ/taurocholate cotransporting polypeptide (ntcp) in hepatocytes. J. Hepatol. 61, 867–875.

  • Konig, A., Yang, J., Jo, E., Park, K.H.P., Kim, H., Than, T.T., Song, X.Y., Qi, X.X., Dai, X.H., Park, S., Shum, D., Ryu, W.S., Kim, J.H., Yoon, S.K., Park, J.Y., Ahn, S.H., Han, K.H., Gerlich, W.H., Windisch, M.P., 2019. Efficient long-term amplification of hepatitis b virus isolates after infection of slow proliferating hepg2-ntcp cells. J. Hepatol. 71, 289–300.

  • Ladner, S.K., Otto, M.J., Barker, C.S., Zaifert, K., Wang, G.H., Guo, J.T., Seeger, C., King, R.W., 1997. Inducible expression of human hepatitis b virus (hbv) in stably transfected hepatoblastoma cells: a novel system for screening potential inhibitors of hbv replication. Antimicrob. Agents Chemother. 41, 1715–1720.

  • Lin, J., Gu, C., Shen, Z., Liu, Y., Wang, W., Tao, S., Cui, X., Liu, J., Xie, Y., 2017.Hepatocyte nuclear factor 1alpha downregulates hbv gene expression and replication by activating the nf-kappab signaling pathway. PLoS One 12, e0174017.

  • Lopez-Cabrera, M., Letovsky, J., Hu, K.Q., Siddiqui, A., 1990. Multiple liver-specific factors bind to the hepatitis b virus core/pregenomic promoter: trans-activation and repression by ccaat/enhancer binding protein. Proc. Natl. Acad. Sci. U. S. A. 87, 5069–5073.

  • Lutgehetmann, M., Mancke, L.V., Volz, T., Helbig, M., Allweiss, L., Bornscheuer, T., Pollok, J.M., Lohse, A.W., Petersen, J., Urban, S., Dandri, M., 2012. Humanized chimeric upa mouse model for the study of hepatitis b and d virus interactions and preclinical drug evaluation. Hepatology 55, 685–694.

  • Nassal, M., Rieger, A., 1996. A bulged region of the hepatitis b virus rna encapsidation signal contains the replication origin for discontinuous first-strand DNA synthesis.J. Virol. 70, 2764–2773.

  • Polaris Observatory, C., 2018. Global prevalence, treatment, and prevention of hepatitis b virus infection in 2016: a modelling study. Lancet Gastroenterol. Hepatol. 3, 383–403.

  • Qiao, L., Sui, J., Luo, G., 2018. Robust human and murine hepatocyte culture models of hepatitis b virus infection and replication. J. Virol. 92 e01255-18.

  • Qin, J., Zhai, J., Hong, R., Shan, S., Kong, Y., Wen, Y., Wang, Y., Liu, J., Xie, Y., 2009.Prospero-related homeobox protein (prox1) inhibits hepatitis b virus replication through repressing multiple cis regulatory elements. J. Gen. Virol. 90, 1246–1255.

  • Raney, A.K., Easton, A.J., Milich, D.R., McLachlan, A., 1991. Promoter-specific transactivation of hepatitis b virus transcription by a glutamine- and proline-rich domain of hepatocyte nuclear factor 1. J. Virol. 65, 5774–5781.

  • Raney, A.K., Kline, E.F., Tang, H., McLachlan, A., 2001. Transcription and replication of a natural hepatitis b virus nucleocapsid promoter variant is regulated in vivo by peroxisome proliferators. Virology 289, 239–251.

  • Rebouissou, S., Zucman-Rossi, J., Moreau, R., Qiu, Z.X., Hui, L.J., 2017. Note of caution:contaminations of hepatocellular cell lines. J. Hepatol. 67, 896–897.

  • Schrem, H., Klempnauer, J., Borlak, J., 2002. Liver-enriched transcription factors in liver function and development. Part i: the hepatocyte nuclear factor network and liverspecific gene expression. Pharmacol. Rev. 54, 129–158.

  • Schrem, H., Klempnauer, J., Borlak, J., 2004. Liver-enriched transcription factors in liver function and development. Part ii: the c/ebps and d site-binding protein in cell cycle control, carcinogenesis, circadian gene regulation, liver regeneration, apoptosis, and liver-specific gene regulation. Pharmacol. Rev. 56, 291–330.

  • Schulze, A., Schieck, A., Ni, Y., Mier, W.,, Urban, S., 2010. Fine mapping of pre-s sequence requirements for hepatitis b virus large envelope protein-mediated receptor interaction. J. Virol. 84, 1989–2000.

  • Seeger, C., Mason, W.S., 2000. Hepatitis b virus biology. Microbiol. Mol. Biol. Rev. 64, 51–68.

  • Shen, Z., Yang, H., Yang, S., Wang, W., Cui, X., Zhou, X., Liu, W., Pan, S., Liu, Y., Zhang, J., Zhang, J., Xie, Y., Liu, J., 2017. Hepatitis b virus persistence in mice reveals il-21 and il-33 as regulators of viral clearance. Nat. Commun. 8, 2119.

  • Tan, M., Bhadoria, A.S., Cui, F., Tan, A., Van Holten, J., Easterbrook, P., Ford, N., Han, Q., Lu, Y., Bulterys, M., Hutin, Y., 2021. Estimating the proportion of people with chronic hepatitis b virus infection eligible for hepatitis b antiviral treatment worldwide: a systematic review and meta-analysis. Lancet Gastroenterol. Hepatol. 6, 106–119.

  • Tang, H., McLachlan, A., 2001. Transcriptional regulation of hepatitis b virus by nuclear hormone receptors is a critical determinant of viral tropism. Proc. Natl. Acad. Sci. U.S. A. 98, 1841–1846.

  • Tang, H., McLachlan, A., 2002. Mechanisms of inhibition of nuclear hormone receptordependent hepatitis b virus replication by hepatocyte nuclear factor 3beta. J. Virol. 76, 8572–8581.

  • Tang, H., Banks, K.E., Anderson, A.L., McLachlan, A., 2001. Hepatitis b virus transcription and replication. Drug News Perspect. 14, 325–334.

  • Trepo, C., Chan, H.L., Lok, A., 2014. Hepatitis b virus infection. Lancet 384, 2053–2063.

  • Wang, W., Sun, L., Li, T., Ma, Y., Li, J., Liu, Y., Li, M., Wang, L., Li, C., Xie, Y., Wen, Y., Liang, M., Chen, L., Tong, S., 2016. A human monoclonal antibody against small envelope protein of hepatitis b virus with potent neutralization effect. mAbs 8, 468–477.

  • Yan, H., Zhong, G., Xu, G., He, W., Jing, Z., Gao, Z., Huang, Y., Qi, Y., Peng, B., Wang, H., Fu, L., Song, M., Chen, P., Gao, W., Ren, B., Sun, Y., Cai, T., Feng, X., Sui, J., Li, W., 2012. Sodium taurocholate cotransporting polypeptide is a functional receptor for human hepatitis b and d virus. Elife 1, e00049.

  • Yu, X., Mertz, J.E., 1996. Promoters for synthesis of the pre-c and pregenomic mrnas of human hepatitis b virus are genetically distinct and differentially regulated. J. Virol. 70, 8719–8726.

  • Yu, X., Mertz, J.E., 2003. Distinct modes of regulation of transcription of hepatitis b virus by the nuclear receptors hnf4alpha and coup-tf1. J. Virol. 77, 2489–2499.

  • Zhang, W., Chen, J., Wu, M., Zhang, X., Zhang, M., Yue, L., Li, Y., Liu, J., Li, B., Shen, F., Wang, Y., Bai, L., Protzer, U., Levrero, M., Yuan, Z., 2017. Prmt5 restricts hepatitis b virus replication through epigenetic repression of covalently closed circular DNA transcription and interference with pregenomic rna encapsidation. Hepatology 66, 398–415.

  • Zhao, K., Liu, S., Chen, Y., Yao, Y., Zhou, M., Yuan, Y., Wang, Y., Pei, R., Chen, J., Hu, X., Zhou, Y., Zhao, H., Lu, M., Wu, C., Chen, X., 2018. Upregulation of hbv transcription by sodium taurocholate cotransporting polypeptide at the postentry step is inhibited by the entry inhibitor myrcludex b. Emerg. Microb. Infect. 7, 186.

  • Zhou, M., Zhao, K., Yao, Y., Yuan, Y., Pei, R., Wang, Y., Chen, J., Hu, X., Zhou, Y., Chen, X., Wu, C., 2017. Productive hbv infection of well-differentiated, hntcpexpressing human hepatoma-derived (huh7) cells. Virol. Sin. 32, 465–475.